Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lenalidomide × Gastrointestinal × Clear all

Phase

Phase 1 5 Phase 2 3 Phase 1/2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 4 Other hematologic neoplasm 3 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Colonoscopy 58 Blood Specimen Collection 57 Exercise 50 Standard of Care 48 Drug Therapy 47 Radiosurgery 44 Endoscopic Mucosal Resection 44 Radiofrequency Ablation 43 Radiotherapy 40 Methods 40 Surgical Procedures, Operative 38 Early Intervention, Educational 37 Oxaliplatin 36 Surveys and Questionnaires 35 Educational Status 32 Fluorouracil 31 Laparoscopy 29 Magnetic Resonance Spectroscopy 27 Preoperative Exercise 25 Gemcitabine 23 Control Groups 22 Electroporation 21 Capecitabine 21 Biopsy 21 Practice Guidelines as Topic 20 Patient Navigation 20 Liver Transplantation 19 lenvatinib 18 Saline Solution 18 Hepatectomy 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07184424 2025-09-19

Lenalidomide

Beijing Tsinghua Chang Gung Hospital

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡